Developing a liquid biopsy test for the early-detection of stomach cancer.
Ilico Genetics has raised $540K in total funding. The most recent round was Convertible Note. The last funding was announced in November 2024.
Ilico Genetics's investors include Ben Franklin Technology Partners of Northeastern Pennsylvania, Life Sciences Greenhouse of Pennsylvania, Las Chauchas SpA.
Ilico Genetics is headquartered in Bethlehem, United States.
Developing a liquid biopsy test for the early-detection of stomach cancer.
Ilico Genetics is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ilico Genetics — Funding & Investors." VCBacked, November 30, 2024, https://www.vcbacked.co/company/ilico-genetics. Accessed August 14, 2026.
VCBacked. (2024). Ilico Genetics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/ilico-genetics
{{cite web |title=Ilico Genetics — Funding & Investors |url=https://www.vcbacked.co/company/ilico-genetics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated